BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33121237)

  • 21. Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1.
    Tausch E; Beck P; Schlenk RF; Jebaraj BJ; Dolnik A; Yosifov DY; Hillmen P; Offner F; Janssens A; Babu GK; Grosicki S; Mayer J; Panagiotidis P; McKeown A; Gupta IV; Skorupa A; Pallaud C; Bullinger L; Mertens D; Döhner H; Stilgenbauer S
    Haematologica; 2020 Oct; 105(10):2440-2447. PubMed ID: 33054084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.
    Benedetti D; Tissino E; Pozzo F; Bittolo T; Caldana C; Perini C; Martorelli D; Bravin V; D'Agaro T; Rossi FM; Bomben R; Santinelli E; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Del Poeta G; Rossi D; Gaidano G; Dal Bo M; Gattei V; Zucchetto A
    Leukemia; 2018 Mar; 32(3):654-662. PubMed ID: 28935990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion.
    Yin S; Gambe RG; Sun J; Martinez AZ; Cartun ZJ; Regis FFD; Wan Y; Fan J; Brooks AN; Herman SEM; Ten Hacken E; Taylor-Weiner A; Rassenti LZ; Ghia EM; Kipps TJ; Obeng EA; Cibulskis CL; Neuberg D; Campagna DR; Fleming MD; Ebert BL; Wiestner A; Leshchiner I; DeCaprio JA; Getz G; Reed R; Carrasco RD; Wu CJ; Wang L
    Cancer Cell; 2019 Feb; 35(2):283-296.e5. PubMed ID: 30712845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New boys in town: prognostic role of SF3B1, NOTCH1 and other cryptic alterations in chronic lymphocytic leukemia and how it works.
    Filip AA
    Leuk Lymphoma; 2013 Sep; 54(9):1876-81. PubMed ID: 23343182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia.
    Jelloul FZ; Yang R; Garces S; Kanagal-Shamanna R; Ok CY; Loghavi S; Routbort MJ; Zuo Z; Yin CC; Floyd K; Bassett RL; Wierda W; Jain N; Thompson P; Luthra R; Medeiros LJ; Patel KP
    Leuk Res; 2022 May; 116():106827. PubMed ID: 35430388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SF3B1 mutations in chronic lymphocytic leukemia.
    Wan Y; Wu CJ
    Blood; 2013 Jun; 121(23):4627-34. PubMed ID: 23568491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.
    Maura F; Cutrona G; Mosca L; Matis S; Lionetti M; Fabris S; Agnelli L; Colombo M; Massucco C; Ferracin M; Zagatti B; Reverberi D; Gentile M; Recchia AG; Bossio S; Rossi D; Gaidano G; Molica S; Cortelezzi A; Di Raimondo F; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
    Leuk Lymphoma; 2015; 56(11):3150-8. PubMed ID: 25860243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the 3'UTR region of the NOTCH1 gene in chronic lymphocytic leukemia patients.
    Abramenko IV; Bilous NI; Chumak AA; Dyagil IS; Martina ZV
    Exp Oncol; 2018 Oct; 40(3):211-217. PubMed ID: 30284999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A reduced panel of eight genes (ATM, SF3B1, NOTCH1, BIRC3, XPO1, MYD88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemia.
    Chauzeix J; Pastoret C; Donaty L; Gachard N; Fest T; Feuillard J; Rizzo D
    Int J Lab Hematol; 2021 Aug; 43(4):683-692. PubMed ID: 33325634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
    Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
    Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia.
    Rasi S; Khiabanian H; Ciardullo C; Terzi-di-Bergamo L; Monti S; Spina V; Bruscaggin A; Cerri M; Deambrogi C; Martuscelli L; Biasi A; Spaccarotella E; De Paoli L; Gattei V; Foà R; Rabadan R; Gaidano G; Rossi D
    Haematologica; 2016 Apr; 101(4):e135-8. PubMed ID: 26819056
    [No Abstract]   [Full Text] [Related]  

  • 32.
    Aptullahoglu E; Wallis JP; Marr H; Marshall S; Bown N; Willmore E; Lunec J
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.
    Rossi D; Spina V; Bomben R; Rasi S; Dal-Bo M; Bruscaggin A; Rossi FM; Monti S; Degan M; Ciardullo C; Serra R; Zucchetto A; Nomdedeu J; Bulian P; Grossi A; Zaja F; Pozzato G; Laurenti L; Efremov DG; Di-Raimondo F; Marasca R; Forconi F; Del Poeta G; Gaidano G; Gattei V
    Blood; 2013 Jun; 121(24):4902-5. PubMed ID: 23637131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic data integration in chronic lymphocytic leukemia.
    Fernández-Martínez JL; deAndrés-Galiana EJ; Sonis ST
    J Gene Med; 2017 Jan; 19(1-2):. PubMed ID: 27928896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.
    Pozzo F; Bittolo T; Vendramini E; Bomben R; Bulian P; Rossi FM; Zucchetto A; Tissino E; Degan M; D'Arena G; Di Raimondo F; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Gattei V; Dal Bo M
    Leukemia; 2017 Nov; 31(11):2407-2415. PubMed ID: 28321119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
    Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
    Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.
    Oscier DG; Rose-Zerilli MJ; Winkelmann N; Gonzalez de Castro D; Gomez B; Forster J; Parker H; Parker A; Gardiner A; Collins A; Else M; Cross NC; Catovsky D; Strefford JC
    Blood; 2013 Jan; 121(3):468-75. PubMed ID: 23086750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NOTCH1 mutations in CLL associated with trisomy 12.
    Balatti V; Bottoni A; Palamarchuk A; Alder H; Rassenti LZ; Kipps TJ; Pekarsky Y; Croce CM
    Blood; 2012 Jan; 119(2):329-31. PubMed ID: 22086416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of c-Myc-dependent heterogeneous nuclear ribonucleoprotein A1 promotes proliferation and inhibits apoptosis in NOTCH1-mutated chronic lymphocytic leukemia cells.
    Zou Y; Tang H; Miao Y; Zhu H; Wang L; Fan L; Fu J; Xu W; Li J; Xia Y
    Chin Med J (Engl); 2022 Apr; 135(8):920-929. PubMed ID: 35730371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients.
    Mansouri L; Grabowski P; Degerman S; Svenson U; Gunnarsson R; Cahill N; Smedby KE; Geisler C; Juliusson G; Roos G; Rosenquist R
    Am J Hematol; 2013 Aug; 88(8):647-51. PubMed ID: 23620080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.